Amalgamated Bank Has $13.47 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Amalgamated Bank decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,774 shares of the company's stock after selling 5,259 shares during the quarter. Amalgamated Bank's holdings in HCA Healthcare were worth $13,473,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Stone House Investment Management LLC acquired a new position in shares of HCA Healthcare in the third quarter worth approximately $25,000. BluePath Capital Management LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at $27,000. Centerpoint Advisors LLC bought a new position in HCA Healthcare during the fourth quarter worth $27,000. Bruce G. Allen Investments LLC acquired a new stake in HCA Healthcare during the 4th quarter worth about $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at about $30,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA stock traded down $1.16 during trading on Friday, hitting $307.68. The company's stock had a trading volume of 1,044,928 shares, compared to its average volume of 1,099,878. The business has a fifty day moving average of $322.64 and a 200-day moving average of $297.17. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The company has a market cap of $81.38 billion, a PE ratio of 15.34, a P/E/G ratio of 1.44 and a beta of 1.66.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts' consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm's quarterly revenue was up 11.2% on a year-over-year basis. During the same period in the previous year, the firm earned $4.93 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 20.74 earnings per share for the current year.

HCA Healthcare declared that its board has approved a share buyback plan on Tuesday, January 30th that permits the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 7.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare's dividend payout ratio is currently 13.16%.

Insiders Place Their Bets

In related news, SVP Kathleen M. Whalen sold 4,262 shares of the firm's stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $306.21, for a total value of $1,305,067.02. Following the completion of the transaction, the senior vice president now directly owns 10,250 shares of the company's stock, valued at approximately $3,138,652.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, SVP Kathleen M. Whalen sold 4,262 shares of the company's stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the sale, the senior vice president now directly owns 10,250 shares in the company, valued at $3,138,652.50. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Chad J. Wasserman sold 344 shares of the business's stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the transaction, the senior vice president now directly owns 2,452 shares of the company's stock, valued at approximately $789,470.44. The disclosure for this sale can be found here. Insiders sold 7,127 shares of company stock worth $2,218,364 over the last quarter. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Truist Financial boosted their price target on HCA Healthcare from $320.00 to $345.00 and gave the company a "buy" rating in a research note on Wednesday, January 31st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of HCA Healthcare from $330.00 to $359.00 and gave the company a "buy" rating in a research note on Friday, April 12th. Cantor Fitzgerald restated an "overweight" rating and issued a $335.00 target price on shares of HCA Healthcare in a research note on Wednesday, April 10th. TD Cowen reduced their price objective on HCA Healthcare from $371.00 to $360.00 and set a "buy" rating for the company in a research note on Tuesday. Finally, Wells Fargo & Company increased their target price on HCA Healthcare from $303.00 to $315.00 and gave the stock an "equal weight" rating in a report on Thursday, March 28th. Four analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $316.59.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.